World Medicine, Türkiye’s leading brand in pharmaceutical exports, continues to reinforce its position in the industry through scientific excellence, sustainable quality, and a strong research infrastructure. A new chapter in R&D is beginning with the launch of the WMINOLAB Innovation Laboratory, equipped with high-precision technological instruments that enable advanced technical analyses. Operating with ISO 17025 Accreditation and following a successful first surveillance audit, the laboratory’s continued performance, particularly in advanced analyses, is considered one of the most concrete outcomes of the company’s long-term quality vision.
Going beyond the role of a conventional testing facility, WMINOLAB aims to contribute to the development of the sector through quality management practices, R&D processes, training programs, and academic publications. Commenting on the laboratory’s mission, Dr. Cem Çalışkan, Director of World Medicine WMINOLAB, stated:
“At WMINOLAB, our goal is to institutionalize an approach that is built on scientific accuracy, anticipates sectoral needs, and ensures sustainable quality. ISO 17025 Accreditation is one of the clearest indicators of this approach. With the successful first surveillance audit, we have reinforced our belief that accreditation is not merely a certificate obtained, but a process that supports continuous improvement.”
Dr. Çalışkan described accreditation as “an indicator that continuous improvement has become an institutional culture rather than just a certification.” The company views its success in advanced analyses as one of the most important outcomes of its long-term quality strategy. In addition, WMINOLAB’s regular participation in international proficiency testing programs has officially confirmed that the laboratory has reached a level of competence fully aligned with global standards in specific and advanced scope analyses.
A Strong Interdisciplinary Team and a Dynamic R&D Structure
Distinguished by its highly qualified workforce composed of interdisciplinary experts, WMINOLAB embraces continuous training and academic development as a core institutional value.
Highlighting the importance of team competency, Dr. Cem Çalışkan said:
“One of WMINOLAB’s greatest strengths is its capable team formed by experts from different disciplines. Beyond technical expertise, our team stands out with analytical thinking, problem-solving skills, and an innovative mindset. The foundation of our long-term success lies in our continued investment in human resources.”
With more than 15 years of accumulated R&D expertise, WMINOLAB continuously enhances its analytical capacity and strengthens its ability to produce scientific solutions by bringing together specialists from different fields.
Contributing to the Industry Through Scientific Publications
Viewing the sharing of scientific knowledge as a corporate responsibility, WMINOLAB also contributes to the sector by publishing its experience on academic platforms. In particular, its work in specialized analyses such as Extractables & Leachables (E&L), Franz Diffusion, Polarography, and Nitrosamine testing has become a key reference point within the industry.
Concluding his remarks, Dr. Çalışkan stated:
“We develop all our work with the principle of sustainability, and we continue to move forward with determination to commercialize technological know-how and expand the dissemination of scientific knowledge. As WMINOLAB, we will continue to work with a strong sense of responsibility to represent our country in the best possible way, as a team with global-standard R&D competence.”
